Terje Rolf Pedersen
Oslo University Hospital
1 paper in the Anchorcite directory, published in 2017, cited 6,357 times in total.
ORCID profileResearch topics
- Lipoproteins and Cardiovascular Health · 1 paper
- Acute Myocardial Infarction Research · 1 paper
- Atherosclerosis and Cardiovascular Diseases · 1 paper
Frequent co-authors
- Marc Steven Sabatine · 1 paper
- Robert Patrick Giugliano · 1 paper
- ANTHONY C. KEECH · 1 paper
- Narimon Honarpour · 1 paper
- Stephen D. Wiviott · 1 paper
- Sabina A. Murphy · 1 paper
- Julia Kuder · 1 paper
- Huei Wang · 1 paper
Papers
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular DiseaseNew England Journal of Medicine · 2017 · 6,357 citations
BACKGROUND: Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS: We conducted a randomized, double-blind, placebo-controlled trial involving…
Metadata from OpenAlex (CC0).